Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Non Operating Income (2017 - 2025)

Selectis Health's Non Operating Income history spans 11 years, with the latest figure at $595102.0 for Q3 2025.

  • For Q3 2025, Non Operating Income rose 155.84% year-over-year to $595102.0; the TTM value through Sep 2025 reached $400841.0, up 108.81%, while the annual FY2024 figure was $239981.0, 19.05% down from the prior year.
  • Non Operating Income for Q3 2025 was $595102.0 at Selectis Health, up from $584420.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $1.6 million in Q2 2024 and bottomed at -$5.3 million in Q4 2023.
  • The 5-year median for Non Operating Income is $51856.0 (2021), against an average of -$269841.0.
  • The largest annual shift saw Non Operating Income tumbled 16264.72% in 2023 before it surged 3033.81% in 2024.
  • A 5-year view of Non Operating Income shows it stood at -$2.2 million in 2021, then soared by 101.53% to $32990.0 in 2022, then crashed by 16264.72% to -$5.3 million in 2023, then skyrocketed by 89.79% to -$544458.0 in 2024, then surged by 209.3% to $595102.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Non Operating Income are $595102.0 (Q3 2025), $584420.0 (Q2 2025), and -$234223.0 (Q1 2025).